Abstract
Chimeric antigen receptor (CAR) T cells have enjoyed unprecedented clinical success against haematological malignancies in recent years. However, several aspects of CAR T cell biology remain unknown. We recently compared CAR and T cell receptor (TCR)-based killing in the same effector cell and showed that CAR T cells can not only efficiently kill single tumor targets, they can also kill multiple tumor targets in a sequential manner. Single and serial killing events were not sustained long term due to CAR down-regulation after 20 hours.
| Original language | English |
|---|---|
| Journal | OncoImmunology |
| Volume | 4 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2 Dec 2015 |
| Externally published | Yes |
Keywords
- CAR
- serial killing
- T cell therapy
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver